185 related articles for article (PubMed ID: 34209690)
21. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
Shie JH; Liu HT; Wang YS; Kuo HC
BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of Frankincense and Myrrha in Treatment of Acute Interstitial Cystitis/Painful Bladder Syndrome.
Chen YH; Chen WC; Tsai KS; Liu PL; Tsai MY; Lin TC; Yu SC; Chen HY
Chin J Integr Med; 2020 Jul; 26(7):519-526. PubMed ID: 32279153
[TBL] [Abstract][Full Text] [Related]
23. Wnt/β-Catenin Pathway in Experimental Model of Fibromyalgia: Role of Hidrox
D'Amico R; Cordaro M; Siracusa R; Impellizzeri D; Trovato Salinaro A; Scuto M; Ontario ML; Crea R; Cuzzocrea S; Di Paola R; Fusco R; Calabrese V
Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829912
[TBL] [Abstract][Full Text] [Related]
24. Platelet-Rich Plasma Ameliorates Cyclophosphamide-Induced Acute Interstitial Cystitis/Painful Bladder Syndrome in a Rat Model.
Chen YH; Man KM; Chen WC; Liu PL; Tsai KS; Tsai MY; Wu YT; Chen HY
Diagnostics (Basel); 2020 Jun; 10(6):. PubMed ID: 32521683
[TBL] [Abstract][Full Text] [Related]
25. Effects of pharmacological neurotrophin receptor inhibition on bladder function in female mice with cyclophosphamide-induced cystitis.
Hsiang HW; Girard BM; Ratkovits L; Campbell SE; Vizzard MA
Front Urol; 2022; 2():. PubMed ID: 37701182
[TBL] [Abstract][Full Text] [Related]
26. Pathomechanism of Interstitial Cystitis/Bladder Pain Syndrome and Mapping the Heterogeneity of Disease.
Jhang JF; Kuo HC
Int Neurourol J; 2016 Nov; 20(Suppl 2):S95-104. PubMed ID: 27915472
[TBL] [Abstract][Full Text] [Related]
27. Deletion or pharmacological blockade of TLR4 confers protection against cyclophosphamide-induced mouse cystitis.
de Oliveira MG; Mónica FZ; Calmasini FB; Alexandre EC; Tavares EBG; Soares AG; Costa SKP; Antunes E
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F460-F468. PubMed ID: 29717937
[TBL] [Abstract][Full Text] [Related]
28. MIF mediates bladder pain, not inflammation, in cyclophosphamide cystitis.
Ma F; Kouzoukas DE; Meyer-Siegler KL; Hunt DE; Leng L; Bucala R; Vera PL
Cytokine X; 2019 Mar; 1(1):. PubMed ID: 31289792
[TBL] [Abstract][Full Text] [Related]
29. Anti-vascular endothelial growth factor treatment decreases bladder pain in cyclophosphamide cystitis: a Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network animal model study.
Lai HH; Shen B; Vijairania P; Zhang X; Vogt SK; Gereau RW
BJU Int; 2017 Oct; 120(4):576-583. PubMed ID: 28581681
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic effect of urine-derived stem cells for protamine/lipopolysaccharide-induced interstitial cystitis in a rat model.
Li J; Luo H; Dong X; Liu Q; Wu C; Zhang T; Hu X; Zhang Y; Song B; Li L
Stem Cell Res Ther; 2017 May; 8(1):107. PubMed ID: 28482861
[TBL] [Abstract][Full Text] [Related]
31. Umbilical Cord Mesenchymal Stem Cells Overexpressing Heme Oxygenase-1 Promotes Symptoms Recovery in Cystitis Rats by Alleviating Neuroinflammation.
Gao Q; Gao Z; Su M; Huang Y; Zhang C; Li C; Zhan H; Liu B; Zhou X
Stem Cells Int; 2023; 2023():8887091. PubMed ID: 38020203
[TBL] [Abstract][Full Text] [Related]
32. Functional effects of blocking VEGF/VEGFR2 signaling in the rat urinary bladder in acute and chronic CYP-induced cystitis.
Tooke K; Girard B; Vizzard MA
Am J Physiol Renal Physiol; 2019 Jul; 317(7):F43-F51. PubMed ID: 30995112
[TBL] [Abstract][Full Text] [Related]
33. Spinal cord stimulation ameliorates detrusor over-activity and visceromotor pain responses in rats with cystitis.
Chang HH; Yeh JC; Mao J; Ginsberg DA; Ghoniem G; Rodriguez LV
Neurourol Urodyn; 2019 Jan; 38(1):116-122. PubMed ID: 30411810
[TBL] [Abstract][Full Text] [Related]
34. Evidence for the Role of Mast Cells in Cystitis-Associated Lower Urinary Tract Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study.
Wang X; Liu W; O'Donnell M; Lutgendorf S; Bradley C; Schrepf A; Liu L; Kreder K; Luo Y
PLoS One; 2016; 11(12):e0168772. PubMed ID: 28002455
[TBL] [Abstract][Full Text] [Related]
35. Suppression of adenosine A
Yang Y; Zhang H; Lu Q; Liu X; Fan Y; Zhu J; Sun B; Zhao J; Dong X; Li L
Biochem Pharmacol; 2021 Jan; 183():114340. PubMed ID: 33189675
[TBL] [Abstract][Full Text] [Related]
36. The Effects of Neurokinin-1 Receptor Antagonist in an Experimental Autoimmune Cystitis Model Resembling Bladder Pain Syndrome/Interstitial Cystitis.
Liu BK; Jin XW; Lu HZ; Zhang X; Zhao ZH; Shao Y
Inflammation; 2019 Feb; 42(1):246-254. PubMed ID: 30196377
[TBL] [Abstract][Full Text] [Related]
37. Region-specific changes in the phosphorylation of ERK1/2 and ERK5 in rat micturition pathways following cyclophosphamide-induced cystitis.
Qiao LY; Gulick MA
Am J Physiol Regul Integr Comp Physiol; 2007 Mar; 292(3):R1368-75. PubMed ID: 17110531
[TBL] [Abstract][Full Text] [Related]
38. Purinergic P2X7 receptors as therapeutic targets in interstitial cystitis/bladder pain syndrome; key role of ATP signaling in inflammation.
Taidi Z; Mansfield KJ; Bates L; Sana-Ur-Rehman H; Liu L
Bladder (San Franc); 2019; 6(1):e38. PubMed ID: 32775480
[TBL] [Abstract][Full Text] [Related]
39. Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis: a comparison with non-ulcerative interstitial cystitis and controls.
Lee CL; Jiang YH; Kuo HC
BJU Int; 2013 Dec; 112(8):1156-62. PubMed ID: 23937072
[TBL] [Abstract][Full Text] [Related]
40. Cystitis-induced bladder pain is Toll-like receptor 4 dependent in a transgenic autoimmune cystitis murine model: a MAPP Research Network animal study.
Cui X; Jing X; Lutgendorf SK; Bradley CS; Schrepf A; Erickson BA; Magnotta VA; Ness TJ; Kreder KJ; O'Donnell MA; Luo Y
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F90-F98. PubMed ID: 31091120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
